CAS No. |
69-25-0 |
中文名称 |
23-(6-氨基-2-(3-羟基-2-(1-(5-氧代吡咯烷-2-甲酰基)吡咯烷-2-甲酰胺基)丙酰胺基)己酰胺基)-17-苄基-14-(仲丁基)-5-氨甲酰基-8-异丁基-20-甲基-7,10,13,16,19,22-六氧代-2-硫杂-6,9,12,15,18,21-六氮杂二十五烷-25-酸 |
英文名称 |
23-(6-amino-2-(3-hydroxy-2-(1-(5-oxopyrrolidine-2-carbonyl)pyrrolidine-2-carboxamido)propanamido)hexanamido)-17-benzyl-14-(sec-butyl)-5-carbamoyl-8-isobutyl-20-methyl-7,10,13,16,19,22-hexaoxo-2-thia-6,9,12,15,18,21-hexaazapentacosan-25-oic acid |
别名 |
Q5358600 | GTPL2086 | NCGC00167276-01 | OKY3285J18 | Eledoisina | D07936 | BDBM50008997 | Eledoisina [INN-Spanish] | AB06413 | Eledoisinum | ELD-950 | 5-Oxo-L-prolyl-L-prolyl-L-seryl-L-lysyl-L-aspartyl-L-alanyl-L-phenylalanyl-L-isoleucylglycyl-L-leucyl-L- |
标准英文名 |
23-(6-amino-2-(3-hydroxy-2-(1-(5-oxopyrrolidine-2-carbonyl)pyrrolidine-2-carboxamido)propanamido)hexanamido)-17-benzyl-14-(sec-butyl)-5-carbamoyl-8-isobutyl-20-methyl-7,10,13,16,19,22-hexaoxo-2-thia-6,9,12,15,18,21-hexaazapentacosan-25-oic acid |
分子式 |
C54H85N13O15S |
分子量 |
1188.42
|
精确分子量 |
1187.60
|
SMILES |
CCC(C)C(NC(=O)C(CC1=CC=CC=C1)NC(=O)C(C)NC(=O)C(CC(=O)O)NC(=O)C(CCCCN)NC(=O)C(CO)NC(=O)C1CCCN1C(=O)C1CCC(=O)N1)C(=O)NCC(=O)NC(CC(C)C)C(=O)NC(CCSC)C(N)=O |
标准SMILES |
CC(C)CC(NC(=O)CNC(=O)C(NC(=O)C(CC1=CC=CC=C1)NC(=O)C(C)NC(=O)C(CC(O)=O)NC(=O)C(CCCCN)NC(=O)C(CO)NC(=O)C1CCCN1C(=O)C1CCC(=O)N1)C(C)CC)C(=O)NC(CCSC)C(N)=O |
用途 |
Eledoisin is a selective agonist for NK2 and NK3 receptors; it induces a biphasic cardiovascular response in rats characterized by an initial decrease followed by an increase in systemic blood pressure; it enhances grooming and scratching behaviors in mice when administered intracerebroventricularly; its stimulatory effect is inhibited by NK1 and NK2 receptor antagonists CP99994 and SR48968, respectively. |
InChIKey |
AYLPVIWBPZMVSH-UHFFFAOYSA-N |